Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
about
Juvenile idiopathic arthritis-associated uveitisUnintended Immunological Consequences of Biologic Therapy.Biologics in pediatric psoriasis - efficacy and safety.IL-6 blockade in systemic juvenile idiopathic arthritis - achievement of inactive disease and remission (data from the German AID-registry).Pediatric rheumatology infusion center: report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 Year.
P2860
Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
@en
type
label
Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
@en
prefLabel
Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
@en
P2860
P1476
Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.
@en
P2093
Gerd Horneff
P2860
P304
P356
10.1517/14740338.2015.1042453
P407
P577
2015-07-01T00:00:00Z